Venkateswar K Swamy

7PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 08, 2026
Targeting MAPK Pathways in Skin, Thyroid, and Pancreatic Cancer: A Perspective on Synthetic Inhibitors and Natural Modulators.

|Jan 02, 2025
Role of the transmembrane polar residues on CD151 in cholesterol binding.

Vishal Kumar Sahu, Kiran Bharat Lokhande, Venkateswar K Swamy

|Apr 05, 2023
Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis.

Sangeeta Ballav, Mrinalini Bhosale, Kiran Bharat Lokhande

|Dec 21, 2022
Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer.

Sangeeta Ballav, Kiran Bharat Lokhande, Rohit Singh Yadav

|Nov 02, 2021
Transferrin binding protein-B from Neisseria meningitidis C as a novel carrier protein in glycoconjugate preparation: an in silico approach.

Abhijeet Karale, Kiran Bharat Lokhande, Niraj Shende

|Oct 09, 2021
Novel B, C-ring truncated deguelin derivatives reveals as potential inhibitors of cyclin D1 and cyclin E using molecular docking and molecular dynamic simulation.

Kiran Bharat Lokhande, Payel Ghosh, Shuchi Nagar

Pageof 2

Frequent Collaborators

4 joint publications

Kiran Bharat Lokhande

3 joint publications

Soumya Basu

2 joint publications

Sangeeta Ballav

2 joint publications

Amit Ranjan